Huang H, Ma W, Zeng X, Liu B, et al. Efficacy and Safety of Disitamab Vedotin Combined with Gemcitabine as Neoadjuvant Therapy in Muscle-invasive Bladder Cancer: An Open-label, Multicenter, Single-arm, Phase 2 Trial. Eur Urol 2025 Nov 4:S0302-2838(25)04768-2. doi: 10.1016/j.eururo.2025.
PMID: 41193372